Editas Medicine
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.
5
Funding Rounds
$656.6m
Money raised
Overview
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.
-
Website:
- Business model: B2B B2C
- Headquarters: Cambridge, Massachusetts
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Fe** Zh*** | - | - | |
| Je* Do**** | - | - | - |
| J. Ke*** Jo*** | - | - | linkedin twitter |
| Ge**** Ch**** |
|
- | linkedin twitter |
| Je* Do**** |
|
- | linkedin twitter facebook instagram |
| Name | Phone | Social networks | |
|---|---|---|---|
| An**** Hi**** | - | - | |
| Ja*** Mu**** | - | - | linkedin twitter |
| GI O锟�*** M.** | - | - | |
| em** re*** | - | - | |
| Da*** Sc |
|
- |
Industries
Editas Medicine is active in the following industries:
- Pharmaceutical industry
- Therapeutics
- Genetic engineering
- Healthcare
- Biomedical engineering
- Genomics
- Technology
- RNA-based and RNA-targeted therapeutics
- Synthetic biology
- Biology
- Biotechnology
- Genome editing
- Regenerative medicine
- Tissue engineering
- Engineering
- Synthetic chemistry
- Induced pluripotent stem cell